Consensus
The community is narrowly leaning bullish on Novartis at 58%, based on 7 forecasts. Forecasters are in moderate agreement.
Resolves YES if Novartis's price 90 days out is above its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole nvs discussion →